Vero Science
Biotechnology, 1334 Main Rd, Tiverton, Rhode Island, 02878, United States, 11-50 Employees
Phone Number: 40********
Who is VEROSCIENCE
VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, a...
Read More
-
Headquarters: 1334 Main Rd, Tiverton, Rhode Island, 02878, United States
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from VEROSCIENCE
VeroScience Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding VeroScience
Answer: VeroScience's headquarters are located at 1334 Main Rd, Tiverton, Rhode Island, 02878, United States
Answer: VeroScience's phone number is 40********
Answer: VeroScience's official website is https://veroscience.com
Answer: VeroScience's revenue is $1 Million to $5 Million
Answer: VeroScience's SIC: 8731
Answer: VeroScience has 11-50 employees
Answer: VeroScience is in Biotechnology
Answer: VeroScience contact info: Phone number: 40******** Website: https://veroscience.com
Answer: VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research. VeroScience researchers study biological clocks in vertebrates and their organizational influence on neuroendocrine regulation of physiology to develop new treatment strategies for metabolic and immune disorders. By investigating and mimicking natures means of regulating biochemical physiology for survival of vertebrates in the wild, VeroScience develops treatment strategies, not products per se, aimed at re-directing pathological biochemistry back towards its normal physiological organization. A major platform technology of the company is Circadian Neuroendocrine Resetting Therapy that is utilized as a generator of multiple therapeutic strategies to treat a variety of disease states. The circadian timed daily (morning) administration of Cycloset, a quick release formulation of bromocriptine mesylate (bromocriptine-QR), a dopamine agonist, was developed for the treatment of type 2 diabetes. Cycloset is approved by the U.S. FDA, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month